Is Virchow's triad complete?

Blood

Volumn 114, Issue 6, 2009, Pages 1138-1139

  Kyrle, Paul A ^a   Eichinger, Sabine ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; ENDOTHELIAL PROTEIN C RECEPTOR; THROMBOMODULIN; VON WILLEBRAND FACTOR;

BLOOD CLOTTING; BLOOD VESSEL WALL; DEEP VEIN THROMBOSIS; ENDOTHELIUM; HUMAN; NOTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; UPREGULATION; VEIN BLOOD FLOW; VEIN VALVE;

EID: 70449478320     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-05-223511     Document Type: Note

References (7)

1. Kyrle PA, Eichinger S. Deep vein thrombosis. Lancet. 2005;365:1163-1164.
2. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet. 1995;345:152-155.
3. van Hylckama Vlieg A, van der Linden IK, Bertina RM, Rosendaal FR.. High levels of factor IX increase the risk of venous thrombosis. Blood. 2000;95:3678-3682. (Pubitemid 30412836)
4. Kyrle PA, Minar E, Hirschl M, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. NEngl J Med. 2000;343:457-462. (Pubitemid 30646484)
5. Weltermann A, Eichinger S, Bialonczyk C, et al. The risk of recurrent venous thromboembolism among patients with high factor IX levels. J Thromb Haemost. 2003;1:28-32.
6. Brooks EG, Trotman W,Wadsworth MP, et al. Valves of the deep venous system: an overlooked risk factor. Blood. 2009;114:1276-1279.
7. Nicolaides AN, Kakkar VV, Field ES, Renney JT. The origin of deep vein thrombosis: a venographic study. Br J Radiol. 1971;44:653-663.